The health and safety of our students, employees, and visitors is of the utmost importance to the University.
If you have questions about how the Vice President for Research, Innovation & Economic Development or Office of Research & Sponsored Programs is handling safety for COVID-19, contact firstname.lastname@example.org or 337-482-5811.
Visit the University's COVID-19 response website for more information about how the University is responding to the COVID-19 pandemic and ensuring the health of all students and employees.
Continuity of operations
Research compliance & Institutional Review Board
New IRB guidelines
Post-award contracts, contract modifications & reporting
COVID-19-related research policies & procedures
COVID-19 funding opportunities
Continuity of Operations
Our recommendations to the research community of UL Lafayette are as follows:
- only “essential personnel,” as designated by their departments are allowed on campus;
- any research that continues on-campus during this period is conducted in a safe manner, consistent with good laboratory hygiene and social distancing guidelines, following CDC best practices; and
- graduate and undergraduate students shall work in research laboratories only if they are designated by their departments as essential personnel.
As the COVID-19 situation expands and the impact evolves, the Office of Vice President for Research, Innovation, and Economic Development (OVPRIED) and the Office of Sponsored Programs Finance Administration and Compliance (SPFAC) are working closely with the University’s leadership team to establish guidance specific to research operations. This guidance is intended to help the campus research community limit the impact and potential risk associated with the growing outbreak of COVID-19.
At the current time, all administrative services of OVPRIED will continue to remain fully operational for the research community. These services include the Office of Research and Sponsored Programs (ORSP), the Office of Innovation Management (OIM), and the Office of Research Integrity (ORI), including research compliance committees such as IRB, IACUC, among others. Likewise, SPFAC is also equipped to serve the campus research community.
All ORSP staff members are available during regular business hours via their UL Lafayette phone numbers, email addresses, and Microsoft Teams accounts. Faculty wishing to meet with ORSP Staff members “in-person” should plan to schedule remote video meetings. ORSP staff can meet via video conference through ZOOM or Microsoft Teams.
At present, all federal agencies are accepting proposals and are processing awards as usual. ORSP staff are fully prepared to support the research community with their proposal submissions through their normal business operations. The Office of Research and Sponsored Programs (ORSP) will continue all normal business operations remotely until further notice.
All ORSP Staff members are available during regular business hours via their UL Lafayette phone numbers, email addresses, and Microsoft Teams accounts.
Faculty wishing to meet with ORSP Staff members “in-person” should plan to schedule remote video meetings. ORSP staff can meet via video conference through ZOOM or Microsoft Teams.
To facilitate planning, at your earliest convenience, please notify your pre-award specialist of any proposals you plan to submit within the next 30-90 days. View the list of pre-awards specialists. Contact Dr. Kumer Das, assistant vice president for OVPRIED, at email@example.com.
Research Compliance & Institutional Review Board
ORI is prepared to provide uninterrupted support to the campus community through various research compliance committees such as IRB, IACUC, Institutional Biosafety Committee, Radiation Safety Committee, among others. All research committee chairs, members, and ORI staff are committed to support your research program.
New IRB Guidelines
During the COVID-19 pandemic, the Institutional Review Board has continued to operate remotely. As the University is forging plans for the safe resumption of on-campus courses and operational functions The IRB has developed a plan to ensure safe re-engagement of human subjects in research involving interpersonal, face-to-face interactions.
Research with remote procedures is preferable during the current phase. However, beginning Monday, June 8, researchers who plan to engage or re-engage human subjects for research involving in-person interactions will need to submit an application or amendment to a previously approved application to the IRB at firstname.lastname@example.org. Read more about the new guidelines.
Contact Dr. Robin Broussard, ORI director, at email@example.com should you have any further questions.
The Office of Innovation Management is continuing operations as normal during the remote work period. Contact Charles “Dean” Domingue, OIM director, at firstname.lastname@example.org should you have any further questions.
Post-Award Contracts, Contract Modifications & Reporting
At present, all federal agencies are processing awards, contracts, contract modifications, reporting, and compliance monitoring as usual. SPFAC staff are fully prepared to support the research community with post-award services through their normal business operations. SPFAC is maintaining and updating a listing of agency provided directives related to sponsored programs. This should be periodically checked to ensure any and all updates related to agencies are considered for the continuity of research operations.
SPFAC is also conducting an analysis of contracts set to expire prior to Tuesday, June 30, to identify and provide assistance to PIs in seeking a No Cost Extension from the sponsor, should COVID-19 cause a significant disruption to your project.
If you believe your funded projects are likely to face disruptions due to COVID-19, please notify your Post-Award Specialist of any specific needs for your contract modifications as soon as identified. View the list of post-awards specialists. Contact Shannon Gary, SPFAC interim director, at email@example.com should you have any questions.
COVID-19 Related Research Policies & Procedures
Under the direction of the Vice President for Research, Innovation, and Economic Development and in accordance with federal, state, and local directives related to COVID-19, the University's research offices have developed interim processes and procedures to ensure that operations and services continue uninterrupted, as much as is possible, during this time.
This page was updated on June 11, 2020, and will be updated regularly, as the COVID-19 situation evolves.
Interim Policies & Procedures In Effect
- Institutional Routing & Approval of Research Proposals via Email - Principle Investigator (PI) Instructions
- NDAs & MOUs – Routing for Approvals
The following acknowledgements and protocols should be used in the case of "emergency" research activities:
- Acknowledgement Form for Returning to Research [Word]
- Clinical / Non-Clinical Research Protocols [Word]
- Field Research Protocols [Word]
- Lab Research Protocols [Word]
COVID-19 Funding Opportunities
There are a number of federal opportunities and agency notices related to COVID-19 research funding opportunities.